Innovating Works
DREAMS: Drug REpurposing with Artificial intelligence for Muscular disorderS SAMSARA THERAPEUTICS LTD participó en un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-two-stage According to World Health Organization, to date, fewer than 6% of rare diseases (RDs) have an approved treatment option. In the light of thi...
2023-10-08 - 2028-10-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.